ONSIOR - Novartis is an effective non-steroidal anti-inflammatory drug (NSAID) thats indicated for the control of postoperative pain and
inflammation associated with orthopedic surgery, ovariohysterectomy and
castration in cats.
Robenacoxib concentrates at the site of inflammation rather than simply
circulating in the bloodstream. This action offers an extra safety
measure to the use of ONSIOR.
Dosage and Administration:
Recommended to use the lowest effective dose for the shortest duration consistent with individual response.
The dose of ONSIOR tablets is 0.45 mg/lb (1 mg/kg)
orally once daily, for a maximum of three days.
Dosage Directions: For oral use in cats ≥ 5.5 lbs and
≥ 4 months of age; for up to a maximum of 3 days. Tablets are not scored
and should not be broken.
The first dose should be administered approximately 30
minutes prior to surgery, at the same time as the pre-anesthetic agents
are given. ONSIOR tablets may be given with or without food.
6 mg ONSIOR (robenacoxib) Tablet
5.5 to 13.2 lbs (2.5 to 6 kg)
1 whole tablet once daily
13.3 to 26.4 lbs (6.1 to 12 kg)
2 whole tablets once daily
ONSIOR tablets should not be used in cats that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs.
Not for use in humans. Keep this and all medications out
of reach of children. Consult a physician in case of accidental
ingestion by humans. For use in cats only.
All cats should undergo a thorough history and physical
examination before the initiation of NSAID therapy. Appropriate
laboratory tests should be conducted to establish hematological and
serum biochemical baseline data prior to administration of an NSAID.
Appetite should be monitored in cats receiving ONSIOR tablets. Stop administration of ONSIOR tablets if appetite decreases. The use of ONSIOR tablets has not been evaluated in cats
younger than 6 months of age, cats weighing less than 5.5 lbs, cats
used for breeding, or in pregnant or lactating cats. The use of ONSIOR tablets in cats with cardiac disease
has not been studied. ONSIOR tablets has been shown to prolong the QT
interval in a laboratory setting.
ONSIOR tablets, like other drugs of its class, is not
free from adverse reactions.
Adverse reactions may include vomiting, diarrhea,
decreased appetite, dark or tarry stools, increased water consumption,
increased urination, anemia, yellowing of gums, skin or white of the eye
due to jaundice, lethargy, incoordination, seizure, or behavioral
changes. Serious adverse reactions associated with this
drug class can occur without warning and in rare situations result in
death. Owners should be advised to
discontinue ONSIOR tablets and contact their veterinarian immediately if
signs of intolerance are observed. The vast majority of patients
with drug related adverse reactions have recovered when the signs are
recognized, the drug is withdrawn, and veterinary care, if appropriate,
ONSIOR tablets are available as 6 mg round flavored
tablets in blisters and are supplied in blister cards containing 3
tablets. The blister cards are supplied in a veterinary carton
containing 10 blister cards and are to be dispensed 1 card per patient
in an ONSIOR tablets dispensing envelope containing veterinary insert
and owner information sheet, supplied with the product.
Store at controlled room temperature, between 59° and 77°F (15-25°C).
Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarianNovartis Animal Health
Rx Medication Sold Only To Licensed Veterinarians & Pharmacies. Current License Must Be On File Prior To Shipping.